2nd World Companion Diagnostics & Liquid Biopsy Summit APAC 2025

 

The World Liquid Biopsy and Companion Diagnostics Summit APAC returns for its second year to bring together over 100 leaders from biopharma, diagnostics, regulation, and healthcare.

As demand for targeted therapies grows, the Asia Pacific region is advancing drug and diagnostic co-development through expanded testing access, policy reform, and public and private collaboration.

Notable progress includes Singapore’s genomic testing scale-up, China’s reimbursement for liquid biopsies, and Japan’s regulatory improvements. Covering oncology, neurology, and rare diseases, the forum will drive regional strategies to accelerate precision medicine and improve patient access.

More Info

---

---